Beyond Air (XAIR) Cash from Financing Activities (2016 - 2025)
Beyond Air's (XAIR) quarterly Cash from Financing Activities came in at $200000.0 in Q4 2025, up 102.17% year-on-year from $98926.3 in Q4 2024, and down 60.0% quarter-over-quarter from $500000.0 in Q3 2025.
Beyond Air (XAIR) Cash from Financing Activities (2016 - 2025) Analysis & Trends
Beyond Air has disclosed Cash from Financing Activities across 10 years of filings, most recently posting $200000.0 for Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at $200000.0, up 102.17% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.3 million (down 66.95% YoY), and the FY2025 annual result was $16.6 million, down 61.44% from the prior year.
- Cash from Financing Activities came in at $200000.0 for Q4 2025 at Beyond Air, down from $500000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $50.7 million in Q4 2021 to a low of -$9.2 million in Q4 2024.
- The 5-year median for Cash from Financing Activities is $4.3 million (2025), against an average of $8.2 million.
- Peak annual rise in Cash from Financing Activities reached 4510.66% in 2024, while the deepest fall reached 275.91% in 2024.
- Beyond Air's Cash from Financing Activities stood at $50.7 million in 2021, then plunged by 100.61% to -$310000.0 in 2022, then jumped by 1789.68% to $5.2 million in 2023, then slumped by 275.91% to -$9.2 million in 2024, then soared by 102.17% to $200000.0 in 2025.
- The last three Cash from Financing Activities figures came in at $200000.0 (Q4 2025), $500000.0 (Q3 2025), and $4.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Beyond Air | 2.53 Mn | -7.33 Mn | 300,000.00 | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 4.07 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | -9.21 Mn |
| Dec 31, 2024 | -9.21 Mn |
| Sep 30, 2024 | 21.62 Mn |
| Sep 30, 2024 | 21.62 Mn |
| Jun 30, 2024 | -264,000.00 |
| Jun 30, 2024 | -264,000.00 |
| Mar 31, 2024 | 15.89 Mn |
| Mar 31, 2024 | 15.89 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Sep 30, 2023 | 469,000.00 |
| Sep 30, 2023 | 469,000.00 |